Lucidplus™ allows you to monitor diabetic ketoacidosis, (DKA) patients with the convenience of using this device anywhere in your facility. Utilizing point-of-care beta-hydroxybutyrate testing has the potential to reduce comprehensive laboratory evaluations for DKA among hyperglycemic emergency-department patients.

Diabetic ketoacidosis (DKA) is a complication of diabetes that occurs when ketones build up in the bloodstream. When your cells don’t get the glucose they need for energy, your body begins to burn fat for energy, which produces ketones. High levels of ketones can poison the body and cause DKA. DKA can lead to diabetic coma or even death. Early diagnosis, monitoring and treatment are usually very effective at preventing serious complications.

• Quantitative results within 10 seconds
• Reportable range of 0.1 – 8.0 mmol/L
• Small sample size, only 0.8 µL
• Whole blood sample, capillary or venous
• Individually wrapped test strips
• Uses AAA batteries
• 1,000 results memory storage
• CLIA waived

Cat. No.: 3100-050SP – Starter Pack includes all
Cat. No.: 300300 – Lucidplus™ Monitoring System
Cat. No.: 3100-050 – Lucidplus™ β-Ketone 50 Test Strips
Cat. No.: 3150-204 – Lucidplus™ β-Ketone Bi-Level Controls (2×4 mL)